DIN 02542021 — GLN-POSACONAZOLE 100 MG
GLN-POSACONAZOLE is a tablet (delayed-release) of Posaconazole marketed by GLENMARK PHARMACEUTICALS CANADA INC.. The full Posaconazole monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02542021
- Brand name
- GLN-POSACONAZOLE
- Active ingredient
- Posaconazole
- Strength
- 100 MG
- Dosage form
- TABLET (DELAYED-RELEASE)
- Route
- ORAL
- Manufacturer
- GLENMARK PHARMACEUTICALS CANADA INC.
- Health Canada status
- MARKETED
- Drug class
- Triazole antifungal agent
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Posaconazole products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02530333 | JAMP POSACONAZOLE | 40 MG | SUSPENSION | JAMP PHARMA CORPORATION | MARKETED |
| 02544644 | MINT-POSACONAZOLE | 100 MG | TABLET (DELAYED-RELEASE) | MINT PHARMACEUTICALS INC | MARKETED |
| 02424622 | POSANOL | 100 MG | TABLET (DELAYED-RELEASE) | MERCK CANADA INC | MARKETED |
| 02293404 | POSANOL | 200 MG | SUSPENSION | MERCK CANADA INC | MARKETED |
| 02432676 | POSANOL | 300 MG | SOLUTION | MERCK CANADA INC | MARKETED |
| 02496259 | SANDOZ POSACONAZOLE | 100 MG | TABLET (DELAYED-RELEASE) | SANDOZ CANADA INCORPORATED | MARKETED |
| 02543311 | TARO-POSACONAZOLE | 100 MG | TABLET (DELAYED-RELEASE) | TARO PHARMACEUTICALS INC | MARKETED |